Evidence map›Paper›PMID 31013963›Full record

ReviewInternational journal of molecular sciences2019

Genes' Interactions: A Major Contributor to the Malignant Transformation of Endometriosis.

Konstantinos Sapalidis, Nikolaos Machairiotis, Paul Zarogoulidis, Sofia Vasilakaki, Chrysanthi Sardeli, George Koimtzis, Efstathios Pavlidis, Athanasios Katsaounis, Dimitrios Giannakidis, Nikolaos Michalopoulos and 5 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Konstantinos SapalidisDepartment of Obstetrics-Gynaecology, Royal Oldham Hospital, Pennine Accute Trust, Oldham OL12JH, UK. sapalidiskonstantinos@gmail.com.
Nikolaos MachairiotisDepartment of Obstetrics-Gynaecology, Royal Oldham Hospital, Pennine Accute Trust, Oldham OL12JH, UK. nikolaosmachairiotis@yahoo.com.
Paul Zarogoulidis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. pzarog@hotmail.com.
Sofia VasilakakiDepartment of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Athens, Greece. svasilak@chem.uoa.gr.
Chrysanthi SardeliDepartment of Pharmacology & Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 52236 Thessaloniki, Greece. sardeli@auth.gr.
George Koimtzis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. drgxkoimtzis@gmail.com.ORCID 0000-0002-0669-6980
Efstathios Pavlidis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. pavlidis.md@gmail.com.
Athanasios Katsaounis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. athanasios_katsaounis@hotmail.com.
Dimitrios Giannakidis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. giannakidis.d@gmail.com.ORCID 0000-0002-8438-4050
Nikolaos Michalopoulos3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. nmichalopoulos1@outlook.com.
Stylianos Mantalobas3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. steliosmantalobas@yahoo.gr.
Vyron Alexandrou3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. vyrwnal@gmail.com.
Charilaos Koulouris3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. charilaoskoulouris@gmail.com.
Aikaterini AmanitiAnesthesiology Department, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 52236 Thessaloniki, Greece. amanitik@gmail.com.
Isaak Kesisoglou3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, 55236 Thessaloniki, Greece. isaackesisoglou@outlook.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic and epigenetic factors that contribute to the malignant transformation of endometriosis are still under investigation. The objective of the present study was to investigate the genetic link between endometriosis and cancer by examining and correlating the latest clinical observations with biological experimental data. We collected updated evidence about the genetic relationship between endometriosis and cancers by conducting a comprehensive search of PubMed and Scopus databases, focusing on the papers published between January 2018 and January 2019. New insights into the mechanism of the malignant transformation of endometriosis have been published recently. The use of state-of-the-art techniques and methods, such as the genome-wide association study analysis and the weighted gene co-expression analysis, have significantly altered our understanding of the association between endometriosis and endometriosis-associated cancer development. Interestingly, the interactions formed between genes seem to play a pivotal role in the phenotypic expression of mutations. Therefore, the effect of single nucleotide polymorphisms and the function of the expression quantitative trait loci on genes' expression have been the subject of many recent works. In addition, it has been discovered that genes, the mutations of which have been related to the development of endometriosis, play a role as hub genes. This may lead to new areas of research for understanding the mechanism of malignant transformation of the disease. Significant steps forward have been made towards the identification of factors that control the malignant transformation of endometriosis. Still, due to rarity of the event, a better-organized scheme for sampling on a global level should be adopted.

Indexed as

BiomarkersCell Transformation, NeoplasticEndometriosisFemaleHumansOvarian NeoplasmsPolymorphism, Single NucleotideQuantitative Trait LociBiomarkersbiomarkercancerendometriosismalignant transformationmutationtumor

Identifiers

PMID31013963
PMCPMC6515388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.